FSIAX vs. FSMEX
Compare and contrast key facts about Fidelity Advisor Strategic Income Fund Class M (FSIAX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX).
FSIAX is managed by Fidelity. It was launched on Oct 31, 1994. FSMEX is managed by Fidelity. It was launched on Apr 28, 1998.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FSIAX or FSMEX.
Key characteristics
| FSIAX | FSMEX | |
|---|---|---|
| YTD Return | 6.39% | 10.57% |
| 1Y Return | 12.65% | 30.42% |
| 3Y Return (Ann) | 0.35% | -7.54% |
| 5Y Return (Ann) | 2.15% | 3.67% |
| 10Y Return (Ann) | 2.84% | 6.54% |
| Sharpe Ratio | 2.96 | 2.08 |
| Sortino Ratio | 4.67 | 2.91 |
| Omega Ratio | 1.62 | 1.36 |
| Calmar Ratio | 1.16 | 0.79 |
| Martin Ratio | 17.85 | 7.72 |
| Ulcer Index | 0.64% | 4.23% |
| Daily Std Dev | 4.00% | 15.67% |
| Max Drawdown | -17.80% | -43.45% |
| Current Drawdown | -0.88% | -23.32% |
Correlation
The correlation between FSIAX and FSMEX is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
FSIAX vs. FSMEX - Performance Comparison
In the year-to-date period, FSIAX achieves a 6.39% return, which is significantly lower than FSMEX's 10.57% return. Over the past 10 years, FSIAX has underperformed FSMEX with an annualized return of 2.84%, while FSMEX has yielded a comparatively higher 6.54% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FSIAX vs. FSMEX - Expense Ratio Comparison
FSIAX has a 0.96% expense ratio, which is higher than FSMEX's 0.68% expense ratio.
Risk-Adjusted Performance
FSIAX vs. FSMEX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Strategic Income Fund Class M (FSIAX) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FSIAX vs. FSMEX - Dividend Comparison
FSIAX's dividend yield for the trailing twelve months is around 4.06%, while FSMEX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FSIAX Fidelity Advisor Strategic Income Fund Class M | 4.06% | 4.05% | 3.37% | 2.44% | 3.06% | 3.18% | 3.39% | 2.88% | 3.23% | 3.46% | 5.08% | 4.94% |
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 11.71% | 5.17% | 9.84% |
Drawdowns
FSIAX vs. FSMEX - Drawdown Comparison
The maximum FSIAX drawdown since its inception was -17.80%, smaller than the maximum FSMEX drawdown of -43.45%. Use the drawdown chart below to compare losses from any high point for FSIAX and FSMEX. For additional features, visit the drawdowns tool.
Volatility
FSIAX vs. FSMEX - Volatility Comparison
The current volatility for Fidelity Advisor Strategic Income Fund Class M (FSIAX) is 0.97%, while Fidelity Select Medical Technology and Devices Portfolio (FSMEX) has a volatility of 4.01%. This indicates that FSIAX experiences smaller price fluctuations and is considered to be less risky than FSMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.